Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-23T13:42:13.993Z Has data issue: false hasContentIssue false
  • English
  • Français

A Case Report of Kratom-Induced Psychiatric Decompensation

Published online by Cambridge University Press:  01 September 2022

E. Garrels ,
G. Gill ,
S. Mitra  and
P. Korenis
E. Garrels*
Affiliation:
BronxCare Health System, Psychiatry, Bronx, United States of America
G. Gill
Affiliation:
BronxCare Health System, Psychiatry, Bronx, United States of America
S. Mitra
Affiliation:
BronxCare Health System, Psychiatry, Bronx, United States of America
P. Korenis
Affiliation:
BronxCare Health System, Psychiatry, Bronx, United States of America
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Kratom (Mitragyna speciosa) is an herb found in South East Asia belonging to the Rubiacea family, the active constituents being Mitragynine and 7-hydroxymitragynine. Sold as a dietary supplement in the form of a leaf, tablet, and powder, it has been gaining popularity as a natural supplement to alleviate pain, anxiety, depression, and manage opioid withdrawal symptoms. Our case report centers around a patient encountered with high-dose Kratom use who presented to our Psychiatric ER with psychosis.

Objectives

The objectives of this case report are to raise awareness regarding the use of a newly popular substance easily available over-the-counter and the potential impacts it has on mental health.

Methods

PubMed was searched for the criteria Kratom AND Intellectual Disability, with a secodary search for Kratom AND Psychosis.

Results

A 29-year-old male with a past psychiatric history of Schizoaffective Disorder, Borderline Intellectual Functioning, Polysubstance Use, ADHD, and six prior suicide attempts was brought to the Psychiatric ED by ambulance activated by his mother for severe psychiatric decompensation following ingestion of 270 pills of Kratom over the course of three days.

Conclusions

This case report further increases awareness of the dangers of Kratom use as well as brings to light the psychoactive properties of Kratom. This case report exposes areas where research can further expand understanding regarding the impacts Kratom can have on psychiatric populations.

Disclosure

No significant relationships.

Keywords

Kratomintellectual disabilityAddictionPsychosis
Type
Abstract
Information
European Psychiatry , Volume 65 , Special Issue S1: Abstracts of the 30th European Congress of Psychiatry , June 2022 , pp. S826
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.